Abstract:Background: Dutasteride, is a drug whose mechanism of action is inhibition of the enzyme 5-alpha reductase. It has been approved for use in the treatment of benign prostatic hyperplasia. Dutasteride has low solubility and high permeability, which classifies it as Biopharmaceutics classification system class II, according to the Biopharmaceutics Classification System. It has a water solubility of only 0.038 ng/mL and a slow dissolving rate, resulting in its exclusive availability in the market as a formulation contained within soft gelatin capsules. Objective: The aim of this study involves two parts. First, is the enhancement of dutasteride dissolution rate, by the creation of dutasteride nanosuspension, and second is the enhancement of patient compliance by the transformation of this nanosuspension to oral fast-dissolving film, which is characterized by its fast disintegration, stability, and ease of administration. Methods: The solvent anti/solvent precipitation method was used to formulate dutasteride nanosuspension. In addition, dutasteride nanoparticles oral fast dissolving films were prepared by using the solvent casting method. To compare the in vitro release patterns of pure dutasteride film and selected dutasteride nanoparticles film, the statistical analysis for the dissolution investigation was conducted using the model-independent technique (employing similarity factor f2) utilizing a DD solver. The selected dutasteride nanoparticle film was supposed to be the test material, while the pure dutasteride film was supposed to serve as the reference. Results: dutasteride nanosuspension demonstrated a high enhancement of the dissolution rate. In addition, the prepared dutasteride nanoparticles oral fast-dissolving film exhibited a further increase in the rate of dissolution and fast disintegration, and the administration is easy, all of these properties making it a promising dosage form. Conclusion: Nanosuspension is an excellent approach for enhancing the solubility, dissolution rate, and effectiveness of drugs with limited aqueous solubility such as dutasteride. In addition, the oral fast-dissolving film can be considered a promising dosage form that will increase patient compliance due to its high dissolution rate, fast disintegration, and easy administration.

Preparation and in vivo evaluation of spray dried matrix type controlled-release microparticles of tamsulosin hydrochloride for orally disintegrating tablet

Development of Novel Tamsulosin Pellet-Loaded Oral Disintegrating Tablet Bioequivalent to Commercial Capsule in Beagle Dogs Using Microcrystalline Cellulose and Mannitol

Preparation of Tamsulosin Hydrochloride-Loaded Mucoadhesive In Situ Gelling Polymeric Formulation for Nasal Delivery in Geriatrics

Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA

Preparation of tolterodine PLGA micorspheres and its in vitro release properties

Formulation and characterization of tadalafil-loaded orodispersible films with enhanced dissolution rate and membrane permeability

Study of Tamsulosin Hydrochloride Sustained- Release Capsules Based on QbD Theory

Preparation and in vitro Release of Doxazosin Mesylate Controlled-Release Tablets

A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.

Method for determination of tamsulosin hydrochloride sustained-release dropping pills and observation on the in vitro release behavior of the pills

Development and Evaluation of an Orodispersible Tablet Formation for the Delivery of a Hydrophobic Drug

Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres

Preparation and Evaluation of Mucus-Penetrating Inhalable Microparticles of Tiotropium Bromide Containing Sodium Glycocholate

Relative bioavailability and phamacokinetics of tamsulosin hydrochloride controlled-release capsules in human volunteers

Preparation and characterization of metformin hydrochloride controlled-release tablet using fatty acid coated granules

Tadalafil-loaded PLGA Microspheres for Pulmonary Administration: Preparation and Evaluation

Preparation and Characterization of Dutasteride Nanoparticles as Oral Fast-Dissolving Film

Preparation and Evaluation of Mosapride Citrate Oral Disintegrating Tablets

Preparation and in Vitro Release Behavior of Urapidil Hydrochloride Loading into Microspheres Based on Poly(l‐lactide)

Aerosol-Assisted Fast Formulating Uniform Pharmaceutical Polymer Microparticles with Variable Properties Toward Ph-Sensitive Controlled Drug Release

Preparation of tilmicosin-resin complex microsphere and its Pharmacokinetics study in rat